• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:毛其芬,王海,陈弘磊,孔凡慧,姜凯.青蒿琥酯增强吉西他滨的抗胰腺癌活性[J].中国现代应用药学,2019,36(8):924-929.
MAO Qifen,WANG Hai,CHEN Honglei,KONG Fanhui,JIANG Kai.Artesunate Enhances the Anti-tumor Effect of Gemcitabine on Pancreatic Cancer[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(8):924-929.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1983次   下载 1167 本文二维码信息
码上扫一扫!
分享到: 微信 更多
青蒿琥酯增强吉西他滨的抗胰腺癌活性
毛其芬, 王海, 陈弘磊, 孔凡慧, 姜凯
浙江省立同德医院, 杭州 310000
摘要:
目的 探讨青蒿琥酯对吉西他滨化疗胰腺癌的辅助治疗作用并研究其机制。方法 MTT法检测胰腺癌细胞系Capan-2在青蒿琥酯和不同浓度吉西他滨处理下的细胞活力。Western blot检测吉西他滨和青蒿琥酯对Capan-2细胞FOXO1、Noxa、Bim表达水平,细胞色素C、Smac/DIABLO从线粒体中的释放量及caspase-9、caspase-3活化水平的影响。流式细胞术检测Capan-2细胞的线粒体膜电位和凋亡率。结果 青蒿琥酯辅助治疗明显提高吉西他滨对Capan-2细胞的杀伤活性。青蒿琥酯处理能显著促进Capan-2细胞FOXO1的表达,转染FOXO1小干扰RNA (FOXO1 siRNA)后,青蒿琥酯对吉西他滨的辅助治疗效果受到明显抑制。青蒿琥酯联合吉西他滨能显著诱导Capan-2细胞中Noxa和Bim的过表达,线粒体膜电位的降低,细胞色素C、Smac/DIABLO的释放,caspase-9、caspase-3的活化及凋亡的发生。转染FOXO1siRNA后,青蒿琥酯联合吉西他滨对Capan-2细胞的凋亡诱导途径受到显著抑制。结论 青蒿琥酯可上调FOXO1的表达,增强吉西他滨对胰腺癌细胞的凋亡诱导活性。
关键词:  青蒿琥酯  FOXO1  吉西他滨  胰腺癌
DOI:10.13748/j.cnki.issn1007-7693.2019.08.006
分类号:R285.5
基金项目:浙江省科技计划项目(2017C37150)
Artesunate Enhances the Anti-tumor Effect of Gemcitabine on Pancreatic Cancer
MAO Qifen, WANG Hai, CHEN Honglei, KONG Fanhui, JIANG Kai
Tongde Hospital of Zhejiang Province, Hangzhou 310000, China
Abstract:
OBJECTIVE To investigate the adjuvant effect and mechanisms of artesunate on gemcitabine-based chemotherapy in pancreatic cancer. METHODS MTT assay was performed to evaluate the effect of artesunate and different concentrations of gemcitabine on changing the cell viability of Capan-2. Western blot analysis was performed to detect the effect of artesunate and gemcitabine on changing the expression of FOXO1, Noxa, Bim, and release of cytochrome C and Smac/DIABLO from mitochondria and activation of caspase-9, caspase-3 in Capan-2 cells. Flow cytometry analysis was performed to detect the mitochondrial membrane potential(Δφ) and apoptosis of Capan-2. RESULTS Adjuvant therapy of artesunate significantly enhanced the killing activity of gemcitabine against pancreatic cancer in vitro. Artesunate significantly promoted the expression of FOXO1 in Capan-2. However, transfection with FOXO1 siRNA obviously suppressed the adjuvant effect of artesunate on gemcitabine. Combination with gemcitabine and artesunate significantly induced the overexpression of Noxa and Bim, release of cytochrome C and Smac/DIABLO, activation of caspase-9 and caspase-3, suppression of Δφ and occurrence of cell apoptosis in Capan-2 cells. On the other hand, transfection with FOXO1 siRNA obviously suppressed the apoptotic pathway induced by the combination treatment with artesunate and gemcitabine in the Capan-2 cells. CONCLUSION Artesunate enhances the activity of gemcitabine on inducing the apoptosis of pancreatic cancer through the upregulation of FOXO1.
Key words:  artesunate  FOXO1  gemcitabine  pancreatic cancer
扫一扫关注本刊微信